Stämm had the pleasure of attending the 30th edition of BIO-Europe, held in Stockholm from November 4-6, 2024. We were represented by our CFO, Juan Martín Cabaleiro, Ph.D., and our Head of BD & Commercial Strategy, Roman Ortega Bianchi, who had the opportunity to engage with leaders from across the biopharma and biotech industries.

This year’s BIO-Europe event was particularly memorable: the program took attendees on a journey through 30 years of key partnerships, deals, and innovations. At the same time, it looked ahead to the next 30 years of possibilities, highlighting the evolving landscape of global biopharma and biotech.

BIO-Europe is a key event for Stämm. It offers us the opportunity to showcase the depth and breadth of our solutions, from biomanufacturing and bioengineering to the advanced capabilities of Bio AI. Our diverse portfolio addresses a wide range of needs, and in-person events like BIO-Europe allow us to connect with potential partners and give them a detailed, hands-on explanation of what we can deliver.

The event provided invaluable opportunities for us to engage with global industry leaders, biotech innovators, and other key stakeholders. We were particularly excited to connect with familiar and new colleagues with whom we shared insights and discussed potential collaborations that will drive the future of biotech forward.

As we reflect on productive conversations and exciting opportunities from this event, we’re inspired and energized by the potential for continued innovation.

Thank you to everyone who made BIO-Europe a memorable and impactful event.

We look forward to what’s next!